相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
Doo-Sik Kong et al.
ONCOTARGET (2017)
MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer
Zibing Wang et al.
ONCOTARGET (2016)
Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial
Hua Zhao et al.
CLINICAL COLORECTAL CANCER (2016)
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Stephanie L. Goff et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
Zibing Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma
Wei Li et al.
ONCOLOGY LETTERS (2016)
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells
Ji Sung Kim et al.
IMMUNE NETWORK (2016)
Efficacy of cytokine-induced killer cells in the treatment of elderly patients with metastatic pancreatic adenocarcinoma
Wei Li et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
Joon Hyeok Lee et al.
GASTROENTEROLOGY (2015)
Efficacy of RetroNectin-Activated Cytokine-Induced Killer Cell Therapy in Metastatic Brain Tumor Patients
Wei Li et al.
ONCOLOGY RESEARCH AND TREATMENT (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Xiaozhou Yu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Association of Myeloid-derived Suppressor Cells and Efficacy of Cytokine-induced Killer Cell Immunotherapy in Metastatic Renal Cell Carcinoma Patients
Zibing Wang et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
Amir Khammari et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
Runmei Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
Liang Liu et al.
CLINICAL CANCER RESEARCH (2012)
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
Melissa M. Alvarez-Downing et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
C. Hontscha et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Ahmedin Jemal et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
Hui Dong et al.
DIGESTIVE AND LIVER DISEASE (2009)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma:: final results of EORTC 18991, a randomised phase III trial
Alexander M. M. Eggermont et al.
LANCET (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
Amir Khammari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients
N Labarrière et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
CM Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190
JM Kirkwood et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
